reason report
feb boston c-suit meet rain parad
bottom line reinforc convict c-suit
manag meet boston feb compani
well posit win amid transform competit
landscap post mega deal new entrant
maintain competit advantag long time come
reiter estim rais pt also feel
comfort upper end guidanc
achiev upsid innov platform across
optumrx optumcar optuminsight integr execut across
uhc even benefit disrupt caus integr
mega deal new entrant littl penetr
clinic workflow manag well prepar address
propos rebat chang hh even gross margin
neutral fashion though caveat premium senior
increas part unless off-set list price buy part
plan need avoid advers select impress
larg nation health plan deal includ medicaid unlik
focu capit deploy optumcar specialti rx region
plan health hospic opportunist basi
pleasur host c-suit dave
schumach presid uhc john penshorn svp
head ir brett manderfeld vice-president ir boston feb despit
patriot parad jubil citi abl see investor
team one-on-on meet eight lunch
guidanc remain achiev room upsid despit
delay close dmg transact up-front
invest nc medicaid contract implement
manag reiter comfort perform
pressur limit medicaid five market on-going
cost improv medic cost trend remain well control
meaning lower headlin guidanc /- bp
adjust benefit design mix reiter ep
base price-to-earnings averag
ep
net debt total capit
price-to-earnings lt ep growth
estimate lt ep growth compound-annual-growth-rate
compani inform svb leerink llc research
revenu billion ep dilut show ep exclud non-cash amort year quarterli
number may sum full-year number due round
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
year price history/av daili volume mil
optumrx lead total cost care platform integr
briova rx specialti rx drive medic cost structur
improv impress pmpi well
posit continu win amid transform landscap
post mega deal antm ingenio rx fact optumrx
john princ capabl leadership recent enjoy sizeabl health
plan win includ harvard pilgrim bcb sc
retent manag well pbm transit
esrx confid achiev seamless satisfi custom
importantli loss ci member includ strand
well contempl recent guidanc
even confid compani well prepar
address call increas price transpar propos
rebat elimin hh recent medicar rule three
caveat chang expect gross margin neutral given
rebat alreadi pass pbm senior
form premium subsidi though concern remain inevit
broader premium increas part potenti advers select
absent buy across entir market manag convers
activ hhs/cm reduct list price manufactur
optumcar build next year continu
biggest capit deploy prioriti greatest sourc
competit advantag rapidli chang landscap
focu remain deepen footprint target market
broaden penetr biggest focu build
primari care presenc ftc review dmg
resum support de novo build urgent
manag acknowledg potenti shore
acut current sound acquisit hospic presenc
meet need age popul adopt
catalyz consum net promot score np along
econom upsid surgeon mco virtual health
play role import site care seen complementari
physic asset particularli polychron condit manag
even convict ralli power
individu health record ihr best breed platform
domin market share leader digit
healthcar consum expect ralli effect stave
competit threat new entrant
well tradit mcos/tech partnership given consum
rather provid focu date
focu capit deploy substanti
cfo remain optumcar primari care surgeri oncolog
along region health plan specialti pharmaci product line
extens dental vision south american market
potenti health acut hospic manag also
expect remain balanc across share repurchas dividend increas
 see littl likelihood base convers
reinforc convict c-suit manag meet boston feb
compani well posit win amid transform competit
landscap post mega deal new entrant maintain
competit edg long time come reiter estim rais pt
also feel comfort upper end guidanc
achiev upsid innov platform across optumrx optumcar
optuminsight integr execut across uhc even benefit disrupt caus
integr mega deal new entrant littl penetr
clinic workflow manag well prepar address propos rebat chang
hh even gross margin neutral fashion though caveat premium
senior increas part unless off-set list price buy part plan
need avoid advers select impress larg nation health plan deal
includ medicaid unlik focu capit deploy optumcar specialti rx
region plan health hospic opportunist basi
pleasur host c-suit dave wichmann ceo andrew
svp head ir brett manderfeld vice-president ir boston feb despit patriot parad
jubil citi abl see investor team one-on-on meet eight
guidanc remain achiev room upsid despit delay close
dmg transact up-front invest nc medicaid contract
implement manag reiter comfort perform
pressur limit medicaid five market on-going cost improv medic cost trend
remain well control meaning lower headlin guidanc /- bp
adjust benefit design mix reiter ep vs
anticip ep growth continu
svb leerinkconsensusrevenu amort earn weighted-avg share net net ep excl amort flow oper paid repurchas expenditur guidanc investor day consensussvb leerinkconsensussvb leerinkconsensussvb net bpscash group inc
optumrx lead total cost care platform integr briova rx specialti rx
drive medic cost structur improv impress pmpi
well posit continu win amid transform landscap post mega deal
antm ingenio rx fact optumrx john princ capabl leadership recent
enjoy sizeabl health plan win includ harvard pilgrim bcb sc
retent manag well pbm transit esrx confid
achiev seamless satisfi custom importantli loss ci member includ
strand well contempl recent guidanc
continu strength optumrx
manag highlight continu strength optumrx move beyond
tradit pbm model oper pharmaci care servic busi manag note
optumrx see renew rate everi contract win net new growth
benefit keen focu busi consolid
competitor may focus integr effort still management note
becom complac oper dynam competit environ transit
ci live non-disrupt impact guidanc although exact time
transfer yet clear compani expect organ growth overwhelm transfer
live ci ci remain client varieti optum servic
optumrx tradit pbm
optumrx provid advantag provid holist view patient
integr medic rx busi model invent briova rx infus avella
specialti pharmaci genoa healthcar asset moder drug spend evidence-bas
briova avella genoa moder specialti drug spend expect make
drug spend
manag expect revenu growth otherwis flat secular outlook
modest margin compress
optumrx expect grow faster overal pbm market
optumrx wide recogn leader across price formulari design
decemb survey commerci fulli insur broker optumrx wide
view leader key select criteria price formulari design
servic pleas see full broker survey link
unh/optumrx lead price pbm
unh/optumrx lead pbm formulari
unh/optumrx leader pbm network
unh/optumrx lead servic
 expressenvisionmedimpacthumanacv aetunh optumbrok rate pbm basi price expresshumanaprimecv aetunh optumbrok rate pbm basi formulari expressmedimpactenvisionprimehumanaaetna cvsunh optumbrok rate pbm basi servic expressunh optumcv aetbrok rate pbm basi network group inc
even confid compani well prepar address call
increas price transpar propos rebat elimin hh recent
medicar rule three caveat chang expect gross margin neutral given
rebat alreadi pass pbm senior form premium
subsidi though concern remain inevit broader premium increas part
potenti advers select absent buy across entir market manag convers
activ hhs/cm reduct list price manufactur key success factor
manag support hh effort drive price transpar
see possibl near-term given pbm pass rebat
medicar part health plan toward premium subsidi across membership
base caveat remain broad buy across part ma-pd plan
avoid downsid advers select could aris subset plan move rebat
subsid pocket cost highest util senior oppos broader premium
subsidi exist today drug manufactur lower list price commensur
rebat share enjoy substanti margin upsid hh propos
posit manag even see possibl bull thesi privat
adopt bundl ma-pd product may see pick senior stand-alone part plan
ff medicar potenti move ma-pd avoid percentag increas sticker shock
part premium new rebat po share model hh
far commerci andrew witti ceo optum formerli ceo gsk see like
spillov transpar effort rebat elimin commerci
segment well like innov privat sector rather legisl
effort though would help end optum rx uhc leader
drive rebat po benefit highest util across broader mm fulli
insur member base though surpris cvs/aet follow lead
self insur employ slow adopt fear potenti backlash
worker see like increas premium
meet management note optumrx fulli prepar oper profit
world without rebat recal hh recent propos rule effect elimin rebat
medicar part manag medicaid implement timelin call
start date aggress anticip chang prepar
submit part bid june pursuant new rule reiter pass
part rebat plan sponsor focus minim total cost care simpli
rebat maxim fact andrew witti optum ceo optimist
uncertainti around ultim scope timelin hh rule new rule usher era
transpar provid clariti spur innov optumrx report abl
save client adopt synchron medical/pharmaceut program abl
achiev medic cost save per member per year particularli evid
specialti drug util commonli util poly-chron patient
spillov commerci like
hh rule focus rebat medicar medicaid would assuredli spill-
effect commerci market act congress necessari elimin rebat
commerci market management note would impract two list price
drug without substitut similar dynam gener market impract
manag two dispar price scheme vast hard manag accord
manag ultim drug manufactur like need drop list price
reduc rebat base weight averag rebat calcul like affect price
new drug price model need evolv accord management see surg
novel differenti approach pharmaceut manufactur pbm pharmaci
impact negoti power
pbm lobbi vocal import rebat enhanc clout
negoti formulari posit manufactur accord management realli matter
strong mechan ensur reason price done
rebat histor market adjust smart compani develop innov
transpar model valu base price risk take end day accord
manag neutral somewhat posit stimul innov new
transpar way busi
self-fund employ yet embrac point sale po rebat
report pass po rebat mm fulli insur commerci book
seen similar momentum self-insur market instead self-insur employ prefer
use rebat lower premium loath rais premium entir employ base
benefit accru high util
start chang benefit design
management believ may start see drug benefit design chang similar risk-bas medic
benefit design abl take learn risk-bas model get leverag
total cost care appli drug benefit design management note prefer fee-bas contract
scope work much explicit transpar one could think model
optumrx offer tier servic differ price point base procur work
unh integr model moder specialti drug spend biggest driver cost trend
integr medic rx busi model pioneer combin briova rx infus
avella specialti pharmaci genoa healthcar asset moder drug spend
evidence-bas treatment guidelin moder spend via intra-year chang
formulari innov value-bas contract manufactur futur management
optimist biosimilar pay larger role howev still far away
util seen european countri hh hope encourag biosimilar util
via elimin rebat medicar part management note biosimilar would
use substitut medicar part new rule like materi impact
get widespread adopt biosimilar accord manag improv fda guidanc
need along physician familiar comfort prescrib
optumcar build next year continu biggest capit deploy
prioriti greatest sourc competit advantag rapidli chang
landscap focu remain deepen footprint target market broaden
penetr biggest focu build primari care presenc
ftc review dmg resum support de novo build
urgent manag acknowledg potenti shore acut
current sound acquisit hospic presenc meet need age
popul adopt catalyz consum np along
econom upsid surgeon mco virtual health play role import
site care seen complementari physic asset particularli polychron
optum seek reinvent local deliveri
keenli focus drive adopt asc build-out center
target market appropri incent align surgeon health
system importantli push lower-cost asc driven surgeon tend
equiti stake asc also patient satisfact report np
asc consist align provid patient continu drive
optumcar puck head
decemb survey hospit administr found mix shift continu toward
lower cost op rapid pace portend well optumcar administr
report deceler yoy util trend except op continu mix shift
lower cost op site pleas see full util survey link
survey result indic yoy deceler site servic except op
procedur respond survey show continu mix shift lower
cost op freestand set line previou survey reflect broader
trend healthcar across ip servic line util declin op util increas
servic line except knee ent declin margin site servic
util servic line increas
respond show continu mix shift op set
close integr optumcar help drive unh medic cost structur advantag
accord management strongli influenc cost need control whole environ
geograph densiti provid multipl touch point diseas manag unh
broad portfolio care deliveri asset surgeri center sca urgent
medexpress infus specialti behavior health briovarx avella genoa allow
gain leverag cost effici provid care acquisit davita medic
group compani expect close year build unh clinic
procedur perform ip vs op vs ltm ntminpatientoutpatientfreestand group inc
multipl touchpoint give optumcar uniqu advantag chang deliv
optumcar serv million patient primari care practic surgeri
center urgent care hospitalist nurs practition optumcar current
align physician advanc practic clinician past five year optumcar
doubl number care provid expand number payer work
nearli
manag see move value-bas care risk-bear provid key
enabl moder cost across synergist platform uhc optum
evid geographi multipl optumcar asset manag showcas
innov model enabl vertic integr exemplifi wellm advanc
medic group primari physician led practic take financi risk
medicar patient report texa practic number inpati hospit
admiss lower compar tradit medicar southwest central region
intend take learn success model wellm appli broadli
throughout care deliveri network rapidli expand value-bas contract
report network contract repres billion health care spend meaning
incent current tie value-bas care provid
power integr deliveri risk-bas model exemplifi wellm
vast physic presenc management believ win strategi combin
substanti physic presenc overlaid comprehens digit solut situat
healthcar system fail due lack inform peopl late
get treatment compli best cours action particularli evid
polychron patient complex manag digit solut rather
take pcp-focus approach make sure physician best data possibl via ihr
otolog recommend clinic intervent data integr across
urgent care er pharmaci mail order make sure prescript medic intervent
appropri appli compli
management also highlight interest build acut care palli home health
capabl demograph head note
necessarili asset outright intent establish larger presenc high
impact area estim optumhealth revenu grow billion
oper incom increas billion oper margin
optumhealth pois growth
even convict ralli power individu health record ihr
best breed platform domin market share leader digit
healthcar consum expect ralli effect stave competit
threat new entrant well tradit mcos/
partnership given consum rather provid focu date
ralli aim integr across nexu provid consum
digit solut integr benefit design clinic network also offer eas
data access payment solut manag confid acceler consum
adopt alway driven partnership consum aggreg employ
coalit need futur explos innov point
solut back privat equiti continu emerg ralli door
applic easi access member
roll ihr power clinic claim even genom data
conduct measur way across key geographi integr across patient
provid feedback clinician overwhelmingli posit date
member given access anticip roll ihr mm peopl
stage first consum aco unit consum famili
practic serv mm member final geographi geographi basi
ralli individu health record ihr lead structur cost save improv
clinic outcom deeper competit moat encroach
employ coalit disrupt roll mm member year end
manag prove far ahead integr vast digit asset
vertic integr platform via ralli individu health record ihr
manag showcas ralli combin ihr differenti platform
significantli moder cost trend improv clinic outcom unlik myriad point solut
ralli ihr uniqu combin dispar data sourc across claim data
clinic record tie provid network benefit design use advanc analyt
provid context mean data deliv insight recommend
consum clinician real time report close million
gap care million alert peopl physician care
need sometim know
abil combin data dispar sourc turn data action insight
improv clinic outcom uniqu serv competit moat
encroach new entrant larg employ coalit broker consult view
unlik abl match quantum data ralli
ihr captur provid clinic insight moder cost improv qualiti care
would surpris partner employ coalit marri vast data
asset clinic expertis consum aggreg capabl
fast-follow mco aet attain app done partnership
engag digit platform samsung/american telehealth partnership
also nip unh heel howev solut appear larg consumer-
focus yet abl match clinic capabl unh ralli ihr
ultim see ralli front digit health act funnel multipl point
solut management note user drown pool digit health solut patient portal
ralli provid simpl singl point entri necessarili focus own
specif digit asset provid effici access multipl asset occasion may
specif app focu rather want door app
closer look ralli
ralli unh front-end digit health platform provid member comprehens view
health well via easi use app ralli leverag integr claim data
clinic record tie provid network benefit design current roll nearli
mm member ralli allow patient find benefit fit specif need find care provid
base treatment facil provid cost breakdown base member specif benefit
design allow member seamlessli book appoint pay provid
ralli own digit front improv consum experi
close integr ralli unh individu health record ihr power tool goe
well beyond tradit electron health record ehr provid member
provid fully-integr fulli portabl real-tim medic record power medic
ontolog turn data action insight clinic result importantli tradit
ehr captur content unh ihr ihr captur data dispar
sourc includ clinic claim data genom social determin use advanc
analyt close gap care recommend path forward clinic treatment ihr
grab data multipl ehr reliant explicit partnership larger
provid data captur end year ihr creat unh mm
consum access mm care provid ralli user access ihr
fulli portabl integr directli physician work unh individu health record
integr improv outcom patient experi lower cost
ralli ihr provid seamless consum experi real power lie
abil drive clinic intervent prevent much seriou health event road
critic import ihr integr directli clinician workflow
point care provid clinician tool align clinic workflow
drive evid base cost-effect site servic decision-mak
use technolog drive clinic intervent
optuminsight earli inning help health system navig shift valu
base care manag expect immedi transit digniti relationship
revenu cycl manag despit recent close cathol health merger digniti
thc conif relationship cathol expect negoti
on-going may part on-going delay sale conif
meet management highlight intens focu health system recent
start put manag risk total cost care importantli optuminsight abl sit
atop multipl ehr provid scrape data dispar sourc optuminsight pois
drive growth backlog project revenu impress margin
optuminsight continu experi top line growth margin expans
recap optuminsight power capabl
optuminsight serv vast array client across healthcar landscap includ health
plan provid life scienc compani state govern optuminsight deriv solut
foundat deep data pool advanc analyt top foundat
segment bring market three broad portfolio segment technolog research
consult manag servic technolog includ softwar applic point
solut bought term licens agreement mainten year term research
consult busi legaci advisori board acquir multi-year
subscript contract research time materi consult consult
busi consult make one largest healthcar consult manag
servic includ fraction outsourc full-scal function outsourc fastest-
grow solut set larg done outcom basi optuminsight share
success outcom payment integr
invest futur
optuminsight activ invest advanc analyt game chang technolog
come year expect hear advanc technolog like blockchain artifici
intellig neural network machin learn deep learn well genom
continu focu drive total cost care improv clinic result
focu capit deploy substanti cfo remain
optumcar primari care surgeri oncolog along region health plan specialti
pharmaci product line extens dental vision south american market
potenti health post-acut hospic manag also expect remain
balanc across share repurchas dividend increas see littl likelihood base
convers larg nation health plan deal includ medicaid
gener plenti cfo invest growth
trade base case ep rais pt
contempl price-to-earnings averag ep
trade base case ep
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag
assess potenti price-to-earnings expans next month base forward
forecast contempl underli fundament implic healthcar
dcf valuat leverag forward forecast wacc termin growth
rate inform potenti multipl expans along sector compani
specif catalyst expect greater potenti multipl expans dcf valuat
point significantli upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti
rate outperform price target contempl price-to-earnings
averag cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
incom servic oper costsmed product oper incom incom earn growth net share dilut earn per ep ep chang growth sg ratio oper group inc
care risk-bas risk-bas advantag medicar public servic medic part prescript drug group inc
